Targeting the cancer initiating cell: the ultimate target for cancer therapy.
McCubrey JA, Steelman LS, Abrams SL, Misaghian N, Chappell WH, Basecke J, Nicoletti F, Libra M, Ligresti G, Stivala F, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Bonati A, Evangelisti C, Cocco L, Martelli AM.
McCubrey JA, et al. Among authors: stivala f.
Curr Pharm Des. 2012;18(13):1784-95. doi: 10.2174/138161212799859701.
Curr Pharm Des. 2012.
PMID: 22394167
Review.